A divided Supreme Court changed the landscape of administrative law in a recent decision, Kisor v. Wilkie. In Kisor, a slim majority declined to overrule Bowles v. Seminole Rock & Sand Co., Auer v. Robbins and related cases,...more
7/18/2019
/ Administrative Agencies ,
Ambiguous ,
Appeals ,
Auer Deference ,
Kisor v Wilkie ,
Patent Litigation ,
Patents ,
Reasonable Interpretations ,
Remand ,
SCOTUS ,
Stare Decisis ,
USPTO ,
Vacated ,
Veterans' Benefits
On May 21, 2019, the United States District Court for the Northern District of California found that Qualcomm violated the Federal Trade Commission (FTC) Act, in an antitrust decision significant to licensing...more
6/3/2019
/ Anti-Competitive ,
Antitrust Violations ,
Appeals ,
Department of Justice (DOJ) ,
Federal Trade Commission (FTC) ,
FRAND ,
FTC Act ,
Injunctive Relief ,
IP License ,
Licensing Rights ,
Microchip Technology ,
Monopolization ,
Motion To Stay ,
Popular ,
Qualcomm ,
Restraint of Trade ,
Sherman Act ,
Standard Essential Patents ,
Technology Sector
In July 2015, the Court of Justice of the European Union ("ECJ") issued Huawei v. ZTE, a seminal decision detailing how holders of Standard Essential Patents ("SEPs") must license its SEPs on fair, reasonable, and...more
5/28/2019
/ Antitrust Violations ,
Appeals ,
EU ,
European Court of Justice (ECJ) ,
FRAND ,
Huawei ,
Injunctive Relief ,
IP License ,
Market Abuse ,
Netherlands ,
Patent Infringement ,
Patents ,
Standard Essential Patents
Squib of Holding and Key Implication:
The United States Supreme Court, in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., held on January 22, 2019 that "a commercial sale to a third party who is required to keep...more
2/6/2019
/ America Invents Act ,
Amicus Briefs ,
Appeals ,
Assignment of Inventions ,
Confidentiality Agreements ,
Generic Drugs ,
Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc ,
Inventions ,
Manual of Patent Examining Procedure (MPEP) ,
On-Sale Bar ,
Patent Infringement ,
Patents ,
Pharmaceutical Patents ,
Printed Publications ,
Prior Art ,
SCOTUS ,
Solicitor General ,
Teva Pharmaceuticals ,
Third-Party Relationships